Fintel reports that on January 8, 2025, Goldman Sachs downgraded their outlook for Comerica (NYSE:CMA) from Buy to Neutral.
In a tough year for stockpickers, a handful of funds managed to trounce the market. Here’s how they did it—and what they like ...